Preparation and evaluation of the rhenium-188-labelled anti-NCA antigen monoclonal antibody BW 250/183 for radioimmunotherapy of leukaemia

European Journal of Nuclear Medicine

Volumn 26, Issue 10, 1999, Pages 1265-1273

  Seitz, Ulrike ^a   Neumaier, Bernd ^a   Glatting, Gerhard ^a   Kotzerke, Jörg ^a   Bunjes, Donald ^a   Reske, Sven N ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Anti NCA 95 antibody; Direct labelling; Leukaemia; Radioimmunotherapy; Rhenium 188

Indexed keywords

GRANULOCYTE ANTIBODY; MONOCLONAL ANTIBODY; RADIOPHARMACEUTICAL AGENT; RHENIUM 188;

ADULT; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CLINICAL PROTOCOL; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; HUMAN; HUMAN CELL; ISOTOPE LABELING; LEUKEMIA; MALE; RADIATION ABSORPTION; RADIATION DOSE; RADIOCHEMISTRY; RADIOIMMUNOTHERAPY; SCINTIGRAPHY; SCINTILLATION CAMERA;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; CELL ADHESION MOLECULES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, THIN LAYER; FEMALE; FLOW CYTOMETRY; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INJECTIONS, INTRAVENOUS; ISOTOPE LABELING; LEUKEMIA; LEUKOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; QUALITY CONTROL; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOMETRY; RADIOPHARMACEUTICALS; RHENIUM; TISSUE DISTRIBUTION;

EID: 0032834494     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050582     Document Type: Article

References (34)

1. Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack ID, Bush SA, Hui E, Martin PJ, Mitchell D, Press OW, Badger CC, Storb R, Nelp WB, Bernstein ID. Development of a marrow transplant regimen for acute leukaemia using targeted haematopoietic irradiation delivered by 131-I-labelled anti-CD45 antibody, combined with cyclophosphamide and total body irradiation. Blood 1995; 4: 1122-1131.
2. Clift RA, Buckner CD, Appelbaum FR, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill R, McDonald G, Martin P, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen J, Thomas ED. Allogeneic marrow transplantation in patients with acute myeloid leukaemia in first remission: a randomized trial of two irradiation regimens. Blood 1990; 76: 1867-1871.
3. Clift RA, Buckner CD, Appelbaum FR, Bryant E, Bearman SI, Petersen FB, Fisher LD, Anasetti C, Beatty P, Bensinger WI, Doney K, Hill R, McDonald G, Martin P, Meyers J, Sanders J, SingerJ, Stewart P, Sullivan KM, Witherspoon R, Storb R, Hansen JA, Thomas ED. Allogeneic marrow transplantation in patients with chronic myeloid leukaemia in the chronic phase: a randomized trial of two irradiation regimens. Blood 1991; 77: 1660-1665.
4. Schwartz MA, Lovett DR, Redner A, Finn RD, Graham MC, Divgi CR, Dantis L, Gee TS, Andreeff M, Old LJ, Larson SM, Scheinberg DA. Dose-escalation trial of M195 labelled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukaemias. J Clin Oncol 1993; 11: 294-303.
5. Goldenberg DM. Future role of radiolabelled monoclonal antibodies in oncological diagnosis and therapy. Semin Nucl Med 1989; 19: 332-339.
6. Appelbaum FR, Matthews DC, Eary JF, Badger CC, Kellogg M, Press OW, Martin PJ, Fisher DR, Nelp WB, Thomas DE, Bernstein ID. The use of radiolabelled anti-CD33 antibody to augment marow transplantation for acute myelogenous leukaemia. Transplantation 1992; 54: 829-833.
7. Scheinberg DA, Lovett D, Divgi CR, Graham MC, Berman E, Pentlow K, Feirt N, Finn RD, Clarkson BD, Gee TS, Larson SM, Oettgen HF, Old LJ. A phase I trial of monoclonal antibody M195 in acute myelogenous leukaemia: Specific bone marrow targeting and internalization of radionuclide. J Clin Oncol 1991; 9: 478-490.
8. Wahren B, Gadler F, Gahrton G, Hammarström S, Hareland Y, Hydén, Ljungdahl E, Mahlèn A, Rudén U, Wiklund M. NCA: a differentiation antigen of myelopoietic cells in human and hominoid monkeys. Ann NY Acad Sci 1983; 417: 344-358.
9. Hanenberg H, Baumann M, Quentin I, Nagel G, Grosse-Wilde H, von Kleist S, Gobel U, Burdach S, Grunert F. Expression of the CEA gene family members NCA-50/90 and NCA-160 (CD66) in childhood acute lymphoblastic leukaemias (ALLs) and in cell lines of B-cell origin. Leukemia 1994; 8: 2127-2133.
10. Noworolska A, Hardozinska A, Buchegger F, Lawinska B, Richter R. Expression of non-specific cross reacting antigen species in myeloid leukemic patients and healthy subjects. Blut 1989; 58: 69-73.
11. Wilder RB, DeNardo GL, DeNardo SJ. Radioimmunotherapy: recent results and future directions. J Clin Oncol 1996; 14: 1383-1400.
12. Deutsch E, Libson K, Vanderheyden JL, Ketring AR, Maxon HR. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Nucl Med Biol 1986; 13: 465-477.
13. 188Re-Direct labelling of monoclonal antibodies for radioiummunotherapy of solid tumors: biodistribution, normal organ dosimetry, and toxicology. Nucl Med Biol 1998; 25:441-447.
14. Winnard P Jr, Virzi F, Fogarasi M, Ruschowski M, Hnatowich DJ. Investigations of directly labelling antibodoes with rhenium-188. Q J Nucl Med 1996; 40: 151-160.
15. Knapp Jr FF (Russ), Beets AL, Guhlke S, Zamora PO, Bender H, Palmedo H, Biersack HJ. Availability of rhenium-188 from the alumina-based tungsten-188/rhenium-188 generator for preparation of Rhenium-188-labelled radiopharmaceuticals for cancer treatment. Anticancer Res 1997; 17: 1783-1796.
16. 188Re generators. Appl Radiat Isot 1994; 45: 1123-1128.
17. Griffith GL, Goldberg DM, Habibe D, Hansen HJ. Technetium-99m, rhenium-186, and rhenium-188 direct-labelled antibodies. Cancer 1994; 73 Suppl 3: 761-768.
18. 99mTc-labelling kit for antibody imaging. Cancer Res 1990; 50: 7945-7985.
19. Noworolska A, Hardozinska A, Lawinska B, Richter R. Non-specific cross-reacting antigen (NCA) in the individual maturation stages of myeloid cell series. Br J Cancer 1985; 51: 371-377.
20. Bläuenstein P, Locher JT, Seybold K, Koprivova H, Janoki GA, Mäcke HR, Hasler P, Ammann A, Novak-Hofer I, Smith A, Schubiger A. Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody MAb47: a comparison of labelling methods. Eur J Nucl Med 1995; 22: 690-698.
21. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
22. John E, Thakur ML, DeFulvio J, McDevitt MR, Damjanov I. Rhenium-186-labelled monoclonal antibodies for radioimmunotherapy: preparation and evaluation. J Nucl Med 1993; 32: 260-267.
23. Siegel JA, Thomas SR, Stubbs JB, Stabin MG, Hays MT, Koral KF, Robertson JS, Howell RW, Wessels BW, Fisher DR, Weber DA, Brill AB. MIRD pamphlet no. 16: Techniques for quantitative radioparmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates. J Nucl Med 1999; 40: 37S-61S.
24. Stabin MG. MIRDOSE: Personnel computer software for internal dose assessment in nuclear medicine. J Nucl Med 1996; 37: 538-546.
25. Thakur ML, DeFulvio J. Technetium-99m-labelled monoclonal antibodies: evaluation of reducing agents. Nucl Med Biol 1991; 18:227-233.
26. Thakur ML, Defulvio J. Tc-99m labelled monoclonal antibodies for immunoscintigraphy. J Immunol Methods 1991; 237: 217-224.
27. Thakur ML, Defulvio J, Park CH, Damjanov A, Yaghsezian H, Jungkind D, Epstein A, McAfee JG. Technetium-99m-labelled proteins for imaging inflammatory foci. Int J Radiat Appl Instrum B 1991; 18: 605-612.
28. Rhodes BA, Zamora PA, Newell KD, Valdes EF. Tc-99m labelling of murine antibody fragments. J Nucl Med 1986; 27: 685-693.
29. Pak KY, Nedelman MA, Stewart R, Dean RT. A rapid and efficient method of labelling IgG antibodies with Tc-99m and comparison with Tc-99m Fab antibody fragments [abstract]. J Nucl Med 1989; 30: 793.
30. Del Rosario RB, Wahl RL. Site specific radiolabelling of monoclonal antibodies with biotin/streptavidin. Nucl Med Biol 1989; 16: 525-529.
31. Griffiths GL, Goldenberg DM, Knapp FF Jr, Callahan AP, Chang CH, Hansen JH. Direct radiolabelling of monoclonal antibodies with generator-produced rhenium-188 for radioimmunotherapy: labeling and animal biodistribution studies. Cancer Res 1991; 51: 4594-4602.
32. Schwarz A, Steinstrabber A. A novel approach to Tc-99m labelled monoclonal antibodies [abstract]. J Nucl Med 1987; 28:721.
33. Mather SJ, Ellison D. Reduction mediated technetium-99m labelling of monoclonal antibodies [abstract]. J Nucl Med 1990; 31: 682.
34. 99mTc labeling of monoclonal antibodies: radiolabelling and in vitro stability. Nucl Med Biol 1991; 18: 695-703.